Yoshito Takeda Selected Research

Infections

1/2022	Prolonged corticosteroid therapy and cytomegalovirus infection in patients with severe COVID-19.
1/2022	A case of synchronous triple autoimmune disorders secondary to thymoma: Pure red cell aplasia, Good's syndrome, and thymoma-associated multi-organ autoimmunity.
7/2021	Fatal cytomegalovirus pneumonia in a critically ill patient with COVID-19.
2/2004	Increased level of soluble E-selectin in the serum from patients with idiopathic pulmonary fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshito Takeda Research Topics

Disease

32	Neoplasms (Cancer) 04/2024 - 03/2002
22	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 09/2004
11	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2004
10	COVID-19 03/2023 - 01/2021
10	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2018 - 02/2003
9	Lung Neoplasms (Lung Cancer) 07/2022 - 02/2003
8	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 09/2008
6	Inflammation (Inflammations) 01/2024 - 05/2011
6	Emphysema 01/2022 - 05/2011
6	Adenocarcinoma of Lung 01/2022 - 08/2005
5	Fibrosis (Cirrhosis) 01/2024 - 02/2004
5	Pneumonia (Pneumonitis) 01/2023 - 05/2009
5	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2022 - 10/2014
4	Idiopathic Pulmonary Fibrosis 01/2024 - 02/2004
4	Disease Progression 03/2022 - 10/2010
4	Infections 01/2022 - 02/2004
4	Respiratory Insufficiency (Respiratory Failure) 07/2021 - 11/2014
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020 - 07/2012
2	Hypoxia (Hypoxemia) 01/2024 - 01/2021
2	Sepsis (Septicemia) 08/2023 - 01/2022
2	Hypersensitivity (Allergy) 01/2023 - 01/2015
2	Exanthema (Rash) 01/2023 - 01/2015
2	Communicable Diseases (Infectious Diseases) 11/2022 - 05/2012
2	Coinfection 02/2022 - 01/2022
2	Hypertension (High Blood Pressure) 01/2022 - 01/2013
2	Sarcoidosis (Schaumann Disease) 01/2022 - 01/2017
2	Weight Loss (Weight Reduction) 01/2022 - 12/2015
2	Adenocarcinoma 12/2020 - 01/2012
2	Brain Neoplasms (Brain Tumor) 02/2017 - 09/2004
2	Pulmonary Alveolar Proteinosis 01/2017 - 11/2014
2	Idiopathic Interstitial Pneumonias 01/2017 - 10/2014
2	Lung Diseases (Lung Disease) 11/2014 - 01/2013
2	Lymphoma (Lymphomas) 07/2013 - 08/2011
1	Bites and Stings (Sting) 04/2024
1	Asthma (Bronchial Asthma) 03/2024
1	Nasal Polyps (Nasal Polyp) 03/2024
1	Rhinosinusitis 03/2024
1	Respiratory Sounds (Crackle) 01/2024
1	Abscess 01/2023
1	Pathologic Processes 11/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2022

Drug/Important Bio-Agent (IBA)

15	TetraspaninsIBA 01/2020 - 02/2003
12	Proteins (Proteins, Gene)FDA Link 03/2024 - 08/2005
11	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2019
11	Biomarkers (Surrogate Marker)IBA 03/2024 - 05/2012
6	Tyrosine Kinase InhibitorsIBA 01/2023 - 09/2004
6	Gefitinib (Iressa)FDA Link 04/2012 - 09/2004
5	NivolumabIBA 04/2024 - 10/2018
5	RNA (Ribonucleic Acid)IBA 01/2024 - 11/2020
5	ErbB Receptors (EGF Receptor)IBA 01/2023 - 09/2004
4	pembrolizumabIBA 01/2024 - 01/2019
4	VaccinesIBA 01/2023 - 01/2021
4	Pancreatic Elastase (Elastase)IBA 01/2021 - 05/2011
4	AdiponectinIBA 01/2017 - 05/2011
3	Semaphorins (Semaphorin)IBA 02/2024 - 12/2018
3	SteroidsIBA 01/2022 - 01/2017
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2017 - 04/2012
3	AutoantibodiesIBA 01/2017 - 11/2014
3	Phosphotransferases (Kinase)IBA 07/2013 - 03/2007
3	IntegrinsIBA 02/2007 - 02/2003
2	InterferonsIBA 04/2024 - 01/2017
2	Peptides (Polypeptides)IBA 01/2023 - 01/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2022
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2022 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2018
2	Therapeutic UsesIBA 01/2022 - 01/2017
2	Bevacizumab (Avastin)FDA Link 01/2021 - 01/2013
2	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 08/2011
2	Trastuzumab (Herceptin)FDA Link 01/2017 - 03/2015
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 07/2013 - 08/2011
2	ChemokinesIBA 10/2012 - 06/2012
1	Neoplasm Antigens (Tumor Antigens)IBA 04/2024
1	Granzymes (Granzyme)IBA 04/2024
1	TetracyclinesIBA 04/2024
1	Eosinophil PeroxidaseIBA 03/2024
1	IpilimumabIBA 01/2024
1	PlatinumIBA 01/2024
1	ProteomeIBA 01/2024
1	Complement System Proteins (Complement)IBA 01/2024
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2024
1	HLA-A*24:02 antigenIBA 01/2023
1	EpitopesIBA 01/2023
1	Cancer VaccinesIBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	Minocycline (Cyclops)FDA LinkGeneric 01/2023
1	TOR Serine-Threonine KinasesIBA 01/2023
1	Demeclocycline (Declomycin)FDA LinkGeneric 01/2023
1	PolyaminesIBA 01/2023
1	6-methyladenineIBA 01/2023
1	Phosphates (Orthophosphate)IBA 07/2022
1	CPG-oligonucleotideIBA 07/2022
1	OligodeoxyribonucleotidesIBA 07/2022
1	GuanineIBA 07/2022
1	Single-Stranded DNA (DNA, Single Stranded)IBA 07/2022

Therapy/Procedure

15	Therapeutics 03/2023 - 02/2007
9	Drug Therapy (Chemotherapy) 01/2024 - 09/2004
8	Immunotherapy 04/2024 - 04/2010
3	Radiotherapy 01/2022 - 09/2004
2	Artificial Respiration (Mechanical Ventilation) 07/2021 - 09/2018
1	Indwelling Catheters (Indwelling Catheter) 08/2023